circSMAD2 inhibits the epithelial–mesenchymal transition by targeting miR-629 in hepatocellular carcinoma

Xianwei Zhang(Zhongnan Hospital of Wuhan University), Jiancheng Tu(Zhongnan Hospital of Wuhan University)
OncoTargets and Therapy
May 1, 2018
Cited by 74


Related Papers